Universitat Rovira I Virgili De Tarragona CCT

Universitat Rovira I Virgili De Tarragona CCT (URV) is an international, non-profit educational institution based in Tarragona, Spain, registered in the U.S. government's System for Award Management (SAM) since July 2015. As a state-controlled institution of higher learning, URV has established itself as a research-focused university with international collaborative capabilities, particularly in medical and scientific research domains. The organization is equipped to receive federal grant sub-awards, demonstrating its capacity to engage in specialized research projects with U.S. academic and medical institutions.

URV has primarily provided complex medical research support through sub-grant awards, focusing specifically on advanced clinical and metabolomic studies. Its recent federal grant sub-awards have been predominantly with prestigious institutions like Brigham & Women's Hospital and Harvard College, involving intricate research on type 2 diabetes, Alzheimer's dementia prevention, and microbiome investigations. The university's research contributions include supplying critical clinical data, selecting and preparing biological samples (plasma and stool samples), conducting participant assessments, and collaborating on data analysis and manuscript preparation. Specific project scopes have involved examining 620 participants with type 2 diabetes, collecting matched control group data, preparing metagenomic data, and shipping biological samples to research facilities like the Broad Institute for comprehensive metabolomic and genomic analyses. These sub-awards demonstrate URV's specialized expertise in medical research, participant data management, and interdisciplinary scientific collaboration.